McGarry Brian E, Wilcock Andrew D, Gandhi Ashvin D, Grabowski David C, Barnett Michael L
Division of Geriatrics and Aging, Department of Medicine, University of Rochester, Rochester, New York.
Department of Health Services Policy and Practice, Brown University School of Public Health, Providence, Rhode Island.
JAMA Intern Med. 2025 Sep 8. doi: 10.1001/jamainternmed.2025.4411.
Hospitals have reported growing difficulty in discharging patients in a timely manner, often citing bottlenecks in postacute care. Medicare Advantage plans, now the dominant form of Medicare coverage, may contribute to these delays due to administrative and network constraints, yet national evidence is lacking.
To quantify changes in hospital length of stay for Medicare Advantage vs traditional Medicare beneficiaries.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used Medicare claims from 2017 through the third quarter of 2023. The sample included short-stay inpatient admissions to US acute care and critical access hospitals. Adjusted analyses were conducted on a 20% random sample, with subgroup analyses of patients discharged to skilled nursing facilities. Data were analyzed from June 2024 to June 2025.
Medicare coverage type at the time of hospital admission.
Primary outcomes included length of stay (in days) and indicators for extended stays (≥7, ≥14, ≥21, and ≥28 days). Difference-in-differences regression models estimated changes in length of stay for Medicare Advantage relative to traditional Medicare, adjusting for patient demographics and hospital fixed effects.
The sample included 89.3 million hospital admissions. Over the study period, the mean (SD) length of stay for Medicare Advantage admissions increased from 6.0 (5.7) to 7.1 (7.6) days compared with an increase from 5.8 (SD) to 6.3 (SD) days for traditional Medicare. By the end of the study period, Medicare Advantage admissions were 1.2 percentage points (95% CI, 1.0-1.3) more likely than traditional Medicare admissions to last 14 or more days, a 19.5% increase relative to the sample mean at baseline. Relative increases were larger for stays of 21 or more days (1.2 percentage points; 95% CI, 1.0-1.3; a relative increase of 25.1%) and 28 or more days (0.28, 95% CI, 0.23-0.33; a relative increase of 31.9%). Among patients discharged to skilled nursing facilities, the adjusted probability of Medicare Advantage admissions lasting 14 or more days increased by 3.1 percentage points (95% CI, 2.6-3.6) relative to traditional Medicare, a 28.1% increase relative to the baseline sample mean. In 2022 alone, prolonged stays among Medicare Advantage patients accounted for an estimated 1.8 million additional hospital bed-days, equivalent to 288 000 additional admissions with average length of stay.
This cohort study found that from 2017 to 2023, Medicare Advantage beneficiaries experienced disproportionately greater increases in hospital length of stay than traditional Medicare beneficiaries, especially among those discharged to skilled nursing facilities. These trends may reflect insurance-related discharge barriers that contributed to millions of additional hospital bed-days. As Medicare Advantage enrollment continues to grow, addressing barriers to discharge may be critical for improving hospital throughput and patient outcomes.
医院报告称,及时让患者出院的难度越来越大,经常提到急性后护理存在瓶颈。医疗保险优势计划如今是医疗保险覆盖的主要形式,由于行政和网络限制,可能导致这些延迟,但缺乏全国性的证据。
量化医疗保险优势计划参保者与传统医疗保险受益人的住院时间变化。
设计、设置和参与者:这项回顾性队列研究使用了2017年至2023年第三季度的医疗保险理赔数据。样本包括美国急性护理和急救医院的短期住院患者。对20%的随机样本进行了调整分析,并对转入专业护理机构的患者进行了亚组分析。数据于2024年6月至2025年6月进行分析。
住院时的医疗保险覆盖类型。
主要结局包括住院时间(天数)和延长住院时间(≥7天、≥14天、≥21天和≥28天)的指标。差异-in-差异回归模型估计了医疗保险优势计划相对于传统医疗保险的住院时间变化,并对患者人口统计学特征和医院固定效应进行了调整。
样本包括8930万次住院。在研究期间,医疗保险优势计划参保者的平均(标准差)住院时间从6.0(5.7)天增加到7.1(7.6)天,而传统医疗保险参保者的住院时间从5.8(标准差)天增加到6.3(标准差)天。到研究期结束时,医疗保险优势计划参保者住院14天或更长时间的可能性比传统医疗保险参保者高1.2个百分点(95%置信区间,1.0-1.3),相对于基线样本均值增加了19.5%。住院21天或更长时间(1.2个百分点;95%置信区间,1.0-1.3;相对增加25.1%)和28天或更长时间(0.28,95%置信区间,0.23-0.33;相对增加31.9%)的相对增幅更大。在转入专业护理机构的患者中,医疗保险优势计划参保者住院14天或更长时间的调整概率相对于传统医疗保险增加了3.1个百分点(95%置信区间,2.6-3.6),相对于基线样本均值增加了28.1%。仅在2022年,医疗保险优势计划患者的延长住院时间估计额外占用了180万张住院床位日,相当于增加了28.8万次平均住院时间的入院。
这项队列研究发现,从2017年到2023年,医疗保险优势计划参保者的住院时间增幅远大于传统医疗保险受益人,尤其是在转入专业护理机构的患者中。这些趋势可能反映了与保险相关的出院障碍,导致了数百万额外的住院床位日。随着医疗保险优势计划的参保人数持续增加,消除出院障碍对于提高医院周转率和患者治疗效果可能至关重要。